R.m.sincerbeaux Capital Management buys $715,057 stake in HCP (HCP)

HCP (HCP) : R.m.sincerbeaux Capital Management scooped up 3,500 additional shares in HCP during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 18,544 shares of HCP which is valued at $715,057.HCP makes up approximately 0.69% of R.m.sincerbeaux Capital Management’s portfolio.

Other Hedge Funds, Including , Central Trust Co boosted its stake in HCP in the latest quarter, The investment management firm added 3,420 additional shares and now holds a total of 6,702 shares of HCP which is valued at $258,429. HCP makes up approx 0.02% of Central Trust Co’s portfolio.Commonwealth Equity Services Inc reduced its stake in HCP by selling 11,059 shares or 2.9% in the most recent quarter. The Hedge Fund company now holds 369,865 shares of HCP which is valued at $14,206,515. HCP makes up approx 0.12% of Commonwealth Equity Services Inc’s portfolio.Physicians Financial Services reduced its stake in HCP by selling 52 shares or 9.96% in the most recent quarter. The Hedge Fund company now holds 470 shares of HCP which is valued at $17,564. HCP makes up approx 0.01% of Physicians Financial Services’s portfolio.Parasol Investment Management reduced its stake in HCP by selling 243 shares or 3.15% in the most recent quarter. The Hedge Fund company now holds 7,477 shares of HCP which is valued at $279,415. HCP makes up approx 0.29% of Parasol Investment Management’s portfolio.

HCP opened for trading at $39.13 and hit $39.505 on the upside on Monday, eventually ending the session at $39.49, with a gain of 0.92% or 0.36 points. The heightened volatility saw the trading volume jump to 38,07,247 shares. Company has a market cap of $18,465 M.

On the company’s financial health, HCP reported $0.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.70. The company had revenue of $662.20 million for the quarter, compared to analysts expectations of $623.74 million. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. Company shares were Reiterated by Mizuho on Aug 10, 2016 to “Neutral”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .HCP was Initiated by Raymond James to “Underperform” on Jul 26, 2016. HCP was Upgraded by Goldman to ” Neutral” on Jul 8, 2016.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.